{
  "schemaVersion" : 2,
  "registerId" : "F2018L00886",
  "instrumentNumber" : "60/2018",
  "citation" : "Statement of Principles concerning macular degeneration (Balance of Probabilities) (No. 60 of 2018)",
  "conditionName" : "macular degeneration",
  "effectiveFrom" : "2018-07-23",
  "standardOfProof" : "Balance of Probabilities",
  "icdCodes" : [ ],
  "onsetFactors" : [ {
    "paragraph" : "9(1)",
    "text" : "smoking at least 15 pack-years of cigarettes, or the equivalent thereof\r\nin other tobacco products, before the clinical onset of macular\r\ndegeneration, and:\r\n(a) smoking commenced at least five years before the clinical onset\r\nof macular degeneration; and\r\n(b) where smoking has ceased, the clinical onset of macular\r\ndegeneration has occurred within 20 years of cessation",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(2)",
    "text" : "consuming a cumulative total of at least 20 kilograms of alcohol in a\r\ncontinuous period of two years, within the five years before the clinical\r\nonset of macular degeneration",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(3)",
    "text" : "being obese for at least the five years before the clinical onset of\r\nmacular degeneration",
    "definedTerms" : [ {
      "term" : "being obese",
      "definition" : "means having a Body Mass Index (BMI) of 30 or greater.\r\nNote: BMI is also defined in the Schedule 1 – Dictionary."
    } ]
  }, {
    "paragraph" : "9(4)",
    "text" : "having chronic kidney disease within the five years before the clinical\r\nonset of macular degeneration",
    "definedTerms" : [ {
      "term" : "chronic kidney disease",
      "definition" : "means an abnormality of kidney structure or function\r\nthat has been present for at least three months.\r\nNote: an abnormality of kidney structure or function is also defined in the Schedule 1 – Dictionary."
    } ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "9(5)",
    "text" : "smoking at least 15 pack-years of cigarettes, or the equivalent thereof\r\nin other tobacco products, before the clinical worsening of macular\r\ndegeneration, and:\r\n(a) smoking commenced at least five years before the clinical\r\nworsening of macular degeneration; and\r\n(b) where smoking has ceased, the clinical worsening of macular\r\ndegeneration has occurred within 20 years of cessation",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(6)",
    "text" : "consuming a cumulative total of at least 20 kilograms of alcohol in a\r\ncontinuous period of two years, within the five years before the clinical\r\nworsening of macular degeneration",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(7)",
    "text" : "being obese for at least the five years before the clinical worsening of\r\nmacular degeneration",
    "definedTerms" : [ {
      "term" : "being obese",
      "definition" : "means having a Body Mass Index (BMI) of 30 or greater.\r\nNote: BMI is also defined in the Schedule 1 – Dictionary."
    } ]
  }, {
    "paragraph" : "9(8)",
    "text" : "having chronic kidney disease within the five years before the clinical\r\nworsening of macular degeneration",
    "definedTerms" : [ {
      "term" : "chronic kidney disease",
      "definition" : "means an abnormality of kidney structure or function\r\nthat has been present for at least three months.\r\nNote: an abnormality of kidney structure or function is also defined in the Schedule 1 – Dictionary."
    } ]
  }, {
    "paragraph" : "9(9)",
    "text" : "for clinical worsening of wet macular degeneration manifesting as\r\nsubretinal haemorrhage only, having anticoagulant therapy or\r\nthrombolytic therapy, within the seven days before the clinical\r\nworsening of macular degeneration",
    "definedTerms" : [ {
      "term" : "wet macular degeneration",
      "definition" : "means choroidal neovascularisation and retinal\r\nangiomatous proliferation. It is also known as neovascular or exudative\r\nmacular degeneration. Complications include subretinal haemorrhage."
    }, {
      "term" : "thrombolytic therapy",
      "definition" : "means therapeutic administration of a pharmacological\r\nagent which breaks up or dissolves blood clots (such as streptokinase or\r\ntissue plasminogen activator)."
    }, {
      "term" : "anticoagulant therapy",
      "definition" : "means therapeutic administration of a\r\npharmacological agent which suppresses, delays or nullifies blood\r\ncoagulation (such as heparin, warfarin or dicumarol), but excludes\r\nantiplatelet therapy (such as aspirin, clopidogrel, ticlopidine or monoclonal\r\nantibodies and recombinant and chemically synthesised peptides that block\r\nplatelet adhesion or aggregation)."
    } ],
    "conditionVariant" : {
      "name" : "clinical worsening of wet macular degeneration manifesting as subretinal haemorrhage",
      "variantFactors" : [ ]
    }
  }, {
    "paragraph" : "9(10)",
    "text" : "inability to obtain appropriate clinical management for macular\r\ndegeneration",
    "definedTerms" : [ ]
  } ]
}